In the last trading session, 1.13 million Apellis Pharmaceuticals Inc (NASDAQ:APLS) shares changed hands as the company’s beta touched 0.93. With the company’s per share
Apellis Pharmaceuticals Inc (NASDAQ:APLS) has a beta value of 0.88 and has seen 2.72 million shares traded in the last trading session. The company, currently
In today’s recent session, 2.22 million shares of the Apellis Pharmaceuticals Inc (NASDAQ:APLS) have been traded, and its beta is 0.87. Most recently the company’s
Apellis Pharmaceuticals Inc (NASDAQ:APLS)’s traded shares stood at 5.5 million during the last session, with the company’s beta value hitting 0.88. At the close of
Apellis Pharmaceuticals Inc (NASDAQ:APLS)’s traded shares stood at 0.37 million during the last session, with the company’s beta value hitting 0.88. At the last check
In last trading session, Apellis Pharmaceuticals Inc (NASDAQ:APLS) saw 2.1 million shares changing hands with its beta currently measuring 0.89. Company’s recent per share price
Apellis Pharmaceuticals Inc (NASDAQ:APLS) has a beta value of 0.88 and has seen 2.82 million shares traded in the recent trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
